Circulating MicroRNAs as clinical biomarkers in the predictions of pregnancy complications

BioMed Research International

Volumn 2015, Issue , 2014, Pages

  Tsochandaridis, Marthe ^a   Nasca, Laurent ^a   Toga, Caroline ^a   Levy Mozziconacci, Annie ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; BIOLOGICAL MARKER;

FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; BLOOD; EXOSOME; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PLACENTA; PREGNANCY;

BIOMARKERS; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84929648903     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/294954     Document Type: Review

References (65)

1. Y. M. D. Lo, N. Corbetta, P. F. Chamberlain et al., "Presence of fetal DNA in maternal plasma and serum," The Lancet, vol. 350, no. 9076, pp. 485-487, 1997.
2. E. K. Ng, N. B. Tsui, T. K. Lau et al., "mRNA of placental origin is readily detectable in maternal plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 8, pp. 4748-4753, 2003.
3. S. S. Chim, T. K. Shing, E. C. Hung et al., "Detection and characterization of placental microRNAs in maternal plasma," Clinical Chemistry, vol. 54, no. 3, pp. 482-490, 2008.
4. Z. Zhao, K. H. Moley, and A. M. Gronowski, "Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases," Clinical Biochemistry, vol. 46, no. 10-11, pp. 953-960, 2013.
5. D.M.M. Prieto and U. R.Markert, "MicroRNAs in pregnancy," Journal of Reproductive Immunology, vol. 88, no. 2, pp. 106-111, 2011.
6. J. R. Lytle, T. A. Yario, and J. A. Steitz, "Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5UTR as in the 3UTR," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9667-9672, 2007.
7. S. Vimalraj, P. J. Miranda, B. Ramyakrishna, and N. Selvamurugan, "Regulation of breast cancer and bone metastasis by MicroRNAs," Disease Markers, vol. 35, no. 5, pp. 369-387, 2013.
8. M. R. Fabian, N. Sonenberg, andW. Filipowicz, "Regulation of mRNA translation and stability by microRNAs," Annual Review of Biochemistry, vol. 79, pp. 351-379, 2010.
9. L. da Sacco and A. Masotti, "Recent insights and novel bioinformatics tools to understand the role of MicroRNAs binding to 5 untranslated region," International Journal of Molecular Sciences, vol. 14, no. 1, pp. 480-495, 2013.
10. http://www.mirbase.org/index.shtml.
11. D. M. Morales-Prieto, S. Ospina-Prieto, A. Schmidt, W. Chaiwangyen, and U. R. Markert, "Elsevier trophoblast research award lecture: origin, evolution and future of placenta miRNAs," Placenta, vol. 35, pp. S39-S45, 2014.
12. G. Fu, J. Brkic, H. Hayder, and C. Peng, "MicroRNAs in human placental development and pregnancy complications," International Journal of Molecular Sciences, vol. 14, no. 3, pp. 5519-5544, 2013.
13. J. C. Cross, Z. Werb, and S. J. Fisher, "Implantation and the placenta: key pieces of the development puzzle," Science, vol. 266, no. 5190, pp. 1508-1518, 1994.
14. J. D. Aplin, "Developmental cell biology of human villous trophoblast: current research problems,"The International Journal of Developmental Biology, vol. 54, no. 2-3, pp. 323-329, 2010.
15. R. B. Donker, J.-F. Mouillet, D. M. Nelson, and Y. Sadovsky, "The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts," Molecular Human Reproduction, vol. 13, no. 4, pp. 273-279, 2007.
16. L. Ji, J. Brkic,M. Liu, G. Fu, C. Peng, and Y. L.Wang, "Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia," Molecular Aspects of Medicine, vol. 34, no. 5, pp. 981-1023, 2013.
17. H. Seitz, H. Royo, M.-L. Bortolin, S.-P. Lin, A. C. Ferguson- Smith, and J. Cavaill'e, "A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain," Genome Research, vol. 14, no. 9, pp. 1741-1748, 2004.
18. L. Luo, G. Ye, L. Nadeem et al., "Microrna-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal," Journal of Cell Science, vol. 125, no. 13, pp. 3124-3132, 2012.
19. G. Fu, G. Ye, L. Nadeem et al., "MicroRNA-376c impairs transforming growth factor- and nodal signaling to promote trophoblast cell proliferation and invasion," Hypertension, vol. 61, no. 4, pp. 864-872, 2013.
20. D. M. Morales-Prieto, E. Schleussner, and U. R. Markert, "Reduction in miR-141 is induced by leukemia inhibitory factor and inhibits proliferation in choriocarcinoma cell line JEG-3," The American Journal of Reproductive Immunology, vol. 66, no. 1, pp. 57-62, 2011.
21. Y. Dai, Z. Qiu, Z. Diao et al., "MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1," Placenta, vol. 33, no. 10, pp. 824-829, 2012.
22. W.-L. Gao, M. Liu, Y. Yang et al., "The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1)," RNA Biology, vol. 9, no. 7, pp. 1002-1010, 2012.
23. P. Li, W. Guo, J. Zhao et al., "MicroRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells," Clinical Science, vol. 124, no. 1, pp. 27-40, 2013.
24. B. L. Pineles, R. Romero, D. Montenegro et al., "Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia," The American Journal of Obstetrics and Gynecology, vol. 196, no. 3, pp. 261.e1-261.e6, 2007.
25. Y. Bai, W. Yang, H.-X. Yang et al., "Downregulated miR- 195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression," PLoS ONE, vol. 7, no. 6, Article ID e38875, 2012.
26. D. M.Morales-Prieto,W. Chaiwangyen, S. Ospina-Prieto et al., "MicroRNA expression profiles of trophoblastic cells," Placenta, vol. 33, no. 9, pp. 725-734, 2012.
27. M. A.Maccani, J. F. Padbury, and C. J.Marsit, "miR-16 and miR- 21 expression in the placenta is associated with fetal growth," PLoS ONE, vol. 6, no. 6,Article ID e21210, 2011.
28. Y. Zhang, M. Fei, G. Xue et al., "Elevated levels of hypoxiainducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease," Journal of Cellular and Molecular Medicine, vol. 16, no. 2, pp. 249-259, 2012.
29. K. Umemura, S. I. Ishioka, T. Endo, Y. Ezaka, M. Takahashi, and T. Saito, "Roles of microRNA-34a in the pathogenesis of placenta accreta," Journal of Obstetrics and Gynaecology Research, vol. 39, no. 1, pp. 67-74, 2013.
30. Y. Zhang, Z. Diao, L. Su et al., "MicroRNA-155 contributes to preeclampsia by down-regulating CYR61," American Journal of Obstetrics and Gynecology, vol. 202, no. 5, pp. 466-e7, 2010.
31. K. Forbes, F. Farrokhnia, J. D. Aplin, and M. Westwood, "Dicer-dependent miRNAs provide an endogenous restraint on cytotrophoblast proliferation," Placenta, vol. 33, no. 7, pp. 581-585, 2012.
32. Y. Altuvia, P. Landgraf, G. Lithwick et al., "Clustering and conservation patterns of human microRNAs," Nucleic Acids Research, vol. 33, no. 8, pp. 2697-2706, 2005.
33. D. M. Morales-Prieto, S. Ospina-Prieto, W. Chaiwangyen, M. Schoenleben, and U. R. Markert, "Pregnancy-associated miRNA-clusters," Journal of Reproductive Immunology, vol. 97, no. 1, pp. 51-61, 2013.
34. R. B. Donker, J. F. Mouillet, T. Chu et al., "The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes,"MolecularHuman Reproduction, vol. 18,no. 8, Article ID gas013, pp. 417-424, 2012.
35. M.-L. Bortolin-Cavaille, M. Dance, M. Weber, and J. Cavaille, "C19MC microRNAs are processed fromintrons of large Pol-II, non-protein-coding transcripts," Nucleic Acids Research, vol. 37, no. 10, pp. 3464-3473, 2009.
36. M. Noguer-Dance, S. Abu-Amero, M. Al-Khtib et al., "The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta," Human Molecular Genetics, vol. 19, no. 18, pp. 3566-3582, 2010.
37. Y. M. D. Lo, N. Corbetta, P. F. Chamberlain et al., "Presence of fetal DNA in maternal plasma and serum," The Lancet, vol. 350, no. 9076, pp. 485-487, 1997.
38. S. A. Devaney, G. E. Palomaki, J. A. Scott, and D. W. Bianchi, "Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review andmeta-analysis," Journal of the American Medical Association, vol. 306, no. 6, pp. 627-636, 2011.
39. I. Hromadnikova, K. Kotlabova, J. Doucha, K. Dlouha, and L. Krofta, "Absolute and relative quantification of placentaspecific microRNAs in maternal circulation with placental insufficiency-related complications," Journal of Molecular Diagnostics, vol. 14, no. 2, pp. 160-167, 2012.
40. K. Kotlabova, J. Doucha, and I. Hromadnikova, "Placentalspecific microRNA in maternal circulation-identification of appropriate pregnancy-associated microRNAs with diagnostic potential," Journal of Reproductive Immunology, vol. 89, no. 2, pp. 185-191, 2011.
41. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells," Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
42. K. Denzer, M. Kleijmeer, H. Heijnen, W. Stoorvogel, and H. Geuze, "Exosome: from internal vesicle of the multivesicular body to intercellular signaling device," Journal of Cell Science, vol. 113, no. 19, pp. 3365-3374, 2000.
43. B. Toth, C. A. R. Lok, A. Böing et al., "Microparticles and exosomes: impact on normal and complicated pregnancy," AmericanJournal of Reproductive Immunology, vol. 58,no. 5, pp. 389-402, 2007.
44. M. K. McDonald, K. E. Capasso, and S. K. Ajit, "Purification and microRNA profiling of exosomes derived from blood and culturemedia," Journal of Visualized Experiments, vol. 14,no. 76, Article ID e50294, 2013.
45. Y.Ouyang, J. F.Mouillet, C. B. Coyne, andY. Sadovsky, "Review: placenta-specific microRNAs in exosomes-good things come in nano-packages," Placenta, vol. 35, pp. S69-S73, 2014.
46. J. Y. Z. Li, T. Y. Yong, M. Z. Michael, and J. M. Gleadle, "MicroRNAs: are they the missing link between hypoxia and pre-eclampsia?" Hypertension in Pregnancy, vol. 33, no. 1, pp. 102-114, 2014.
47. H. Li, Q. Ge, L. Guo, and Z. Lu, "Maternal plasma miRNAs expression in preeclamptic pregnancies," BioMed Research International, vol. 2013, Article ID 970265, 9 pages, 2013.
48. J. F.Mouillet, T. Chu, C. A. Hubel, D. M. Nelson,W. T. Parks, and Y. Sadovsky, "The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction," Placenta, vol. 31, no. 9, pp. 781-784, 2010.
49. W. Ventura, K. Koide, K. Hori et al., "Placental expression of microRNA-17 and -19b is down-regulated in early pregnancy loss," European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 169, no. 1, pp. 28-32, 2013.
50. L. Anton, A. O. Olarerin-George, N. Schwartz et al., "MiR- 210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia," The American Journal of Pathology, vol. 183, no. 5, pp. 1437-1445, 2013.
51. S. Polsani, E. Phipps, and B. Jim, "Emerging new biomarkers of preeclampsia," Advances in Chronic Kidney Disease, vol. 20, no. 3, pp. 271-279, 2013.
52. C.W. Redman and I. L. Sargent, "Latest advances in understanding preeclampsia," Science, vol. 308, no. 5728, pp. 1592-1594, 2005.
53. C. Liu, Y. Zhou, and Z. Zhang, "MiR-210: an important player in the pathogenesis of preeclampsia?" Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 943-944, 2012.
54. L. M. MacHado Nardozza, E. A. Junior, M. M. Barbosa, A. C. Rabachini Caetano, D. J. Re Lee, and A. F. Moron, "Fetal growth restriction: current knowledge to the general Obs/Gyn," Archives of Gynecology and Obstetrics, vol. 286, no. 1, pp. 1-13, 2012.
55. A. Higashijima, K. Miura, H. Mishima et al., "Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy," Prenatal Diagnosis, vol. 33, no. 3, pp. 214-222, 2013.
56. I. Cetin and G. Alvino, "Intrauterine growth restriction: implications for placental metabolism and transport. A review," Placenta, vol. 30, pp. 77-82, 2009.
57. D. Furness,M. Fenech, G. Dekker, T.Y.Khong,C.Roberts, and W. Hague, "Folate, vitamin B12, vitamin B6 and homocysteine: impact on pregnancy outcome," Maternal and Child Nutrition, vol. 9, no. 2, pp. 155-166, 2013.
58. I. Cetin, C. Mando, and S. Calabrese, "Maternal predictors of intrauterine growth restriction," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 3, pp. 310-319, 2013.
59. Q. Tang, W. Wu, X. Xu et al., "miR-141 contributes to fetal growth restriction by regulating PLAG1 expression," PLoS ONE, vol. 8, no. 3, Article IDe58737, 2013.
60. L. Huang, Z. Shen, Q. Xu, X. Huang, Q. Chen, and D. Li, "Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction," Placenta, vol. 34, no. 7, pp. 624-627, 2013.
61. A. J.Wilcox, C. R.Weinberg, J. F. O'Connor et al., "Incidence of early loss of pregnancy," The New England Journal of Medicine, vol. 319, no. 4, pp. 189-194, 1988.
62. J. Hustin, E. Jauniaux, and J. P. Schaaps, "Histological study of the materno-embryonic interface in spontaneous abortion," Placenta, vol. 11, no. 6, pp. 477-486, 1990.
63. M. B. Kirschner, N. van Zandwijk, and G. Reid, "Cell-free microRNAs: potential biomarkers in need of standardized reporting," Frontiers in Genetics, vol. 4, article 56, 2013.
64. F. D. Malone, J. A. Canick, R. H. Ball et al., "First-trimester or second-trimester screening, or both, for down's syndrome," The New England Journal ofMedicine, vol. 353, no. 19, pp. 2001-2011, 2005.
65. L. Wu, H. Zhou, H. Lin et al., "Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies," Reproduction, vol. 143, no. 3, pp. 389-397, 2012.